PhotoPharmics reaches key milestone in Light for PD trial for Parkinson’s disease
PhotoPharmics, a leader in neurodegenerative disease phototherapy, has reached a significant milestone in its Light for PD clinical trial. The company has enrolled its first 100 subjects, marking an important step in assessing Celeste, an FDA Breakthrough light therapy device designed for Parkinson’s disease (PD). The trial, which aims to recruit a total of 300 […]